Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Mar-Apr;23(2):134-7.
doi: 10.1097/IOP.0b013e31802f208d.

Use of the diode laser with intraoperative mitomycin C in endocanalicular laser dacryocystorhinostomy

Affiliations

Use of the diode laser with intraoperative mitomycin C in endocanalicular laser dacryocystorhinostomy

Raoul D Henson et al. Ophthalmic Plast Reconstr Surg. 2007 Mar-Apr.

Abstract

Purpose: To determine the safety and efficacy of the diode laser with intraoperative mitomycin C in endocanalicular laser dacryocystorhinostomy (ECL-DCR).

Methods: In a prospective case series of 40 ECL-DCRs using the diode laser, mitomycin C was placed intraoperatively in all cases. The main outcome measure was resolution or improvement of epiphora and no major laser damage intranasally. Patients were followed for at least 18 months.

Results: Forty consecutive ECL-DCRs on 30 patients (23 females, 7 males, mean age 62 years) were performed from April 2000 to December 2001. The success rate at 12 months postoperatively was 87.5%. All failures were due to a constricted nasal osteotomy. No significant intraoperative or postoperative complications were recorded.

Conclusions: Diode laser ECL-DCR with mitomycin C appears to be a safe and effective treatment modality for primary acquired nasolacrimal duct obstruction.

PubMed Disclaimer

Similar articles

Cited by

LinkOut - more resources